MedTrace Logo

A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile Women Subjected to Ovulation Induction With Follitropin α

NCT01111084 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 410

Last updated 2014-07-16

No results posted yet for this study

Summary

This is a prospective and multicentric observational study to determine the real mono-bifollicular development rate that is obtained under normal care conditions following ovulation induction (OI) treatment with follitropin-alpha filled by mass prescribed in accordance with standard practice.

Conditions

  • Ovulation Induction

Interventions

DRUG

Follitropin alpha (r-FSH)

The dosage and administration of follitropin alpha was according to each centre's protocol and within technical specification recommendations.

Sponsors & Collaborators

  • Merck KGaA, Darmstadt, Germany

    lead INDUSTRY

Principal Investigators

  • Dr. Enrique Granados · Merck Serono Spain

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2005-06-30
Completion
2005-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01111084 on ClinicalTrials.gov